0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.49%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.93%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-38.09%
Negative EBIT growth while 0259.HK is at 14.84%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.09%
Negative operating income growth while 0259.HK is at 14.84%. Joel Greenblatt would press for urgent turnaround measures.
-46.61%
Negative net income growth while 0259.HK stands at 127.84%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-58.14%
Negative EPS growth while 0259.HK is at 122.58%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-58.14%
Negative diluted EPS growth while 0259.HK is at 122.58%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
27.41%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
27.49%
Diluted share change of 27.49% while 0259.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Dividend reduction while 0259.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-60.86%
Negative OCF growth while 0259.HK is at 28.16%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-86.70%
Negative FCF growth while 0259.HK is at 301.60%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
60253.69%
10Y revenue/share CAGR above 1.5x 0259.HK's 141.01%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-22.50%
Negative 5Y CAGR while 0259.HK stands at 99.01%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-3.23%
Negative 3Y CAGR while 0259.HK stands at 21.97%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1252.02%
10Y OCF/share CAGR above 1.5x 0259.HK's 127.09%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
382.08%
Below 50% of 0259.HK's 1369.62%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
1336.12%
3Y OCF/share CAGR above 1.5x 0259.HK's 17.38%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
334.84%
Net income/share CAGR above 1.5x 0259.HK's 55.38% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
115.27%
Below 50% of 0259.HK's 322.30%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
911.33%
3Y net income/share CAGR above 1.5x 0259.HK's 211.87%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
326.15%
5Y equity/share CAGR above 1.5x 0259.HK's 173.40%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.13%
Positive short-term equity growth while 0259.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0259.HK stands at 499.98%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0259.HK invests at 20.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-14.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
19.80%
We show growth while 0259.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-6.28%
Negative asset growth while 0259.HK invests at 9.81%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.68%
We have a declining book value while 0259.HK shows 15.07%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-40.86%
We’re deleveraging while 0259.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-10.61%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.66%
We expand SG&A while 0259.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.